Newsroom

LUGANO, Switzerland--(BUSINESS WIRE)--SFI Health™ EMEA to launch Equazen® Forte in Poland, a concentrated product formulation to help the cognitive performance for young adults and adults....

LONDON--(BUSINESS WIRE)--  28 January 2026 Next 15 Group plc (“Next 15” or the “Group”) Capital Markets Day Next 15 Group plc (“Next 15” or the “Group”), the data-led growth consultancy, will today host a Capital Markets Day for institutional investors and analysts that will be held in London at 2pm GMT. During the event, management will provide further detail on the Group’s new strategy and priorities, following the actions taken to date to simplify the business, resolve legacy issues and stre...

LONDON--(BUSINESS WIRE)--  28 January 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 27 January 2026, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Peel Hunt LLP (“Peel Hun...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 27 January 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 27 January 2026 Number of Public Shares Purchased: 19...

LONDON--(BUSINESS WIRE)--  28 January 2026 Next 15 Group plc (“Next 15” or the “Group”) Full Year Trading Update Next 15 Group plc (“Next 15” or the “Group”), the data-led growth consultancy, today provides an update on trading for the financial year ending 31 January 2026 (“FY26”), ahead of its Capital Markets Day later today. FY26 performance is anticipated to be in-line with market expectations*, underpinned by robust trading results through the final weeks of 2025. We approach the conclusio...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et prévenir les troubles de la perte auditive, annonce aujourd'hui la réalisation d’une offre réservée à des catégories spécifiques d'investisseurs (l' « Offre Réservée ») d'un montant de 60 millions d'euros, à travers l'émission de 214 285 714 actions ordinaires nouvelles...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced a €60 million offering reserved to specific categories of investors (the “Reserved Offering”) through the issuance of 214,285,714 new ordinary shares of the Company (the “New Shares”) at a price per New Share of €0.28 (the “Subscriptio...

SYDNEY--(BUSINESS WIRE)--WinDC today announced a strategic partnership with Megaport (ASX:MP1) that will connect WinDC’s renewable-powered AI Factories to Megaport’s global Network as a Service platform. The partnership enables high-density AI compute deployed at renewable generation sites to be accessed by organisations across Australia and throughout Megaport’s international network. WinDC’s model introduces a new category of AI infrastructure in the Australian market. Instead of building dat...

GENT, Belgium & MALVERN, Pa. & TOKYO--(BUSINESS WIRE)--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. This CLEIA (chemiluminescent enzyme immunoassay) assay is available for Research Use Only (RUO) and allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human cerebrospinal fluid (CSF) within just 35 minute...

TOKYO--(BUSINESS WIRE)--The NTT Group, comprising NTT, Inc., NTT DOCOMO, INC., and NTT DATA Group Corporation, announced today that they will jointly exhibit at MWC Barcelona 2026, the world’s largest connectivity event, to be held in Barcelona, Spain, from March 2 to March 5, 2026. At this event, the NTT Group will showcase its technological capabilities and foster deeper connections with leading global companies. Under the unified concept introduced following the corporate identity (CI) renew...